Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye

• 收藏
• 分享

专利权人:

Ltd.;Alcon Research

发明人:

Kabra, Bhagwati P.

申请号：

AU2010221438

公开号：

AU2010221438B2

申请日:

2010.03.03

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

Disclosed are efficacious pharmaceutical compositions in the form of intraocular suspensions comprising an anti-angiogenic compound in a therapeutically effective amount and a polyethylene glycol having a molecular weight of at least 2000, preferably at least 3000. The compositions are preferably for treatment of ocular disorders, such as diabetic retinopathy, age-related macular degeneration, macular edema, uveitis, and geographic atrophy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/